FR2805264B1 - Oligonucleotides immunostimulants - Google Patents

Oligonucleotides immunostimulants

Info

Publication number
FR2805264B1
FR2805264B1 FR0002056A FR0002056A FR2805264B1 FR 2805264 B1 FR2805264 B1 FR 2805264B1 FR 0002056 A FR0002056 A FR 0002056A FR 0002056 A FR0002056 A FR 0002056A FR 2805264 B1 FR2805264 B1 FR 2805264B1
Authority
FR
France
Prior art keywords
immunostimulating oligonucleotides
immunostimulating
oligonucleotides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0002056A
Other languages
English (en)
Other versions
FR2805264A1 (fr
Inventor
Monique Bachy
Emmanuelle Trannoy
Regis Sodoyer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Pasteur SA
Original Assignee
Aventis Pasteur SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pasteur SA filed Critical Aventis Pasteur SA
Priority to FR0002056A priority Critical patent/FR2805264B1/fr
Priority to AU2001235617A priority patent/AU2001235617A1/en
Priority to PCT/FR2001/000350 priority patent/WO2001062910A1/fr
Publication of FR2805264A1 publication Critical patent/FR2805264A1/fr
Application granted granted Critical
Publication of FR2805264B1 publication Critical patent/FR2805264B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/117—Nucleic acids having immunomodulatory properties, e.g. containing CpG-motifs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/18—Type of nucleic acid acting by a non-sequence specific mechanism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0002056A 2000-02-18 2000-02-18 Oligonucleotides immunostimulants Expired - Fee Related FR2805264B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR0002056A FR2805264B1 (fr) 2000-02-18 2000-02-18 Oligonucleotides immunostimulants
AU2001235617A AU2001235617A1 (en) 2000-02-18 2001-02-07 Immunostimulatory oligonucleotides
PCT/FR2001/000350 WO2001062910A1 (fr) 2000-02-18 2001-02-07 Oligonucleotides immunostimulants

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0002056A FR2805264B1 (fr) 2000-02-18 2000-02-18 Oligonucleotides immunostimulants

Publications (2)

Publication Number Publication Date
FR2805264A1 FR2805264A1 (fr) 2001-08-24
FR2805264B1 true FR2805264B1 (fr) 2002-04-12

Family

ID=8847155

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0002056A Expired - Fee Related FR2805264B1 (fr) 2000-02-18 2000-02-18 Oligonucleotides immunostimulants

Country Status (3)

Country Link
AU (1) AU2001235617A1 (fr)
FR (1) FR2805264B1 (fr)
WO (1) WO2001062910A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2388049A1 (fr) 2002-05-30 2003-11-30 Immunotech S.A. Oligonucleotides immunostimulateurs et utilisations connexes
EA201290876A1 (ru) 2010-03-05 2013-03-29 Президент Энд Феллоуз Оф Гарвард Колледж Композиции индуцированных дендритных клеток и их использование

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE420171T1 (de) * 1994-07-15 2009-01-15 Univ Iowa Res Found Immunomodulatorische oligonukleotide
CA2289741A1 (fr) * 1997-05-19 1998-11-26 Merck & Co., Inc. Adjuvant oligonucleotidique

Also Published As

Publication number Publication date
AU2001235617A1 (en) 2001-09-03
WO2001062910A1 (fr) 2001-08-30
FR2805264A1 (fr) 2001-08-24

Similar Documents

Publication Publication Date Title
DE60125312D1 (de) Mikroarray
DE60134243D1 (de) Biegevorrichtung
DE60140351D1 (de) Biegevorrichtung
DE60114185D1 (de) Viszerales fettmessgerät
NO20032512D0 (no) Polymeriseringsprosess
DE60133189D1 (de) Aufblasvorrichtung
DE60130189D1 (de) Krimpkontaktbüchse
NO20030276D0 (no) Fremgangsmåte
DE60110137D1 (de) Biochip
DE10196082T1 (de) FLIP-CHIP-Montageverfahren
DE60113294D1 (de) Aufblasvorrichtung
AR028061A1 (es) 2-enamino-cetonitrilos fenil-substituidos
FR2805265B1 (fr) Oligonucleotides immunostimulants
AR027982A1 (es) Aril- y heteroarilsulfonatos
FR2805264B1 (fr) Oligonucleotides immunostimulants
FR2805883B1 (fr) Profile
FIU20000417U0 (fi) Ohjauskytkin
UA4322S (uk) Профіль
UA4727S (uk) Профіль
UA4351S (uk) Профіль
UA4587S (uk) Профіль
UA4588S (uk) Профіль
UA4590S (uk) Профіль
UA4591S (uk) Профіль
UA4592S (uk) Профіль

Legal Events

Date Code Title Description
ST Notification of lapse